Search

Your search keyword '"Francoz, Claire"' showing total 589 results

Search Constraints

Start Over You searched for: Author "Francoz, Claire" Remove constraint Author: "Francoz, Claire"
589 results on '"Francoz, Claire"'

Search Results

2. Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting

3. Identification of liver transplant biopsy phenotypes associated with distinct liver biological markers and allograft survival

4. When Is a Critically Ill Cirrhotic Patient Too Sick to Transplant? Development of Consensus Criteria by a Multidisciplinary Panel of 35 International Experts.

8. Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis

9. AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool

10. SAT-016 Assessment of the role of liver transplantation with or without combined kidney transplantation in polycystic liver or liver and kidney disease

11. SAT-010 Elaboration of a one-year mortality score for first elective liver transplantation recipients over 60 years based on the results of the french national cohort between 2007 and 2017

12. FRI-370 Bulevirtide efficacy and safety in chronic hepatitis delta patients on liver transplant waiting list

13. OS-097 Effect of rifaximin in severe cirrhotic patients with ascites: a double-blind randomized placebo-controlled phase 3 trial

14. SAT-048 Long-term mortality and risk factors associated with mortality after liver transplantation in the modern era

15. THU-079 Pre-transplant work-up for acute-on-chronic liver failure patients in intensive care units, a nationwide french survey

16. Erratum to “EASL Clinical Practice Guidelines on acute-on-chronic liver failure” [J Hepatol 79 (2023) 461–491]

17. R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation

19. Liver Transplantation for Porto-Sinusoidal Vascular Liver Disorder: Long-term Outcome

20. International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria

22. Long term results of liver transplantation for alpha-1 antitrypsin deficiency

25. Recipient age influences survival after liver transplant: Results of the French national cohort 2007–2017.

26. Autoimmune hepatitis recurrence after liver transplantation: “Les jeux sont faits”.

27. Liver transplantation for critically ill cirrhotic patients: Stratifying utility based on pretransplant factors

28. Portopulmonary hypertension in the current era of pulmonary hypertension management

29. Identification of liver transplant biopsy phenotypes associated with distinct liver biological markers and allograft survival

30. Osteoporosis and Fragility Fractures in Patients With Cirrhosis Evaluated for Liver Transplantation: Identification of High-Risk Patients Based on Computed Tomography at Evaluation

31. Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors

32. Autoimmune hepatitis recurrence after liver transplantation: “Les jeux sont faits”

36. Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis.

37. Bariatric surgery and liver transplantation, here we are now: A French nationwide retrospective study

39. When Is a Critically Ill Cirrhotic Patient Too Sick to Transplant? Development of Consensus Criteria by a Multidisciplinary Panel of 35 International Experts

40. Risk Factors and Impact of Perioperative Prophylaxis on the Risk of Extended-spectrum β-Lactamase-producing Enterobacteriaceae-related Infection Among Carriers Following Liver Transplantation

42. Direct-acting antiviral agent–based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study

43. Evaluation of a delayed liver transplant strategy for patients listed for hepatocellular carcinoma treated with resection or thermo-ablation as a bridge to liver transplantation; the DELTAS-HCC study

44. Simvastatin plus Rifaximin to prevent ACLF in patients with decompensated cirrhosis. A randomised, double-blind, placebo-controlled, phase-3 trial: the liverhope efficacy trial

45. Long-term outcome following liver transplantation for chronic liver disease in intensive care unit: the French nationwide experience

48. The Impact of Direct-acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients With Hepatocellular Carcinoma Listed for Liver Transplantation: An International Multicenter Study

49. Novel Benchmark for Adult-to-Adult Living-donor Liver Transplantation.

50. Renal Dysfunction in Patients with Cirrhosis

Catalog

Books, media, physical & digital resources